Exact Sciences (Marlborough, Massachusetts) said it received notice from the Nasdaq stock market that it is not in compliance with the rule requiring a listed security to maintain a minimum $50 million market capitalization. The company said the notice has no immediate effect on its listing and its common stock will continue to trade on the market.
Exact will be provided until Aug. 11 to regain compliance with the rule. The company will regain compliance if it maintains a minimum $50 million market value of its common stock for at least 10 consecutive business days before Aug. 11. If Exact has not regained compliance by Aug. 11, the Nasdaq staff will issue a letter notifying the company that its common stock will be delisted.
CyberKnife Center now open in Tampa
Cutting-edge cancer treatment is now available in the Tampa Bay area of Florida. The CyberKnife Center will serve as an open outpatient cancer and tumor treatment center available for use by all physicians, surgeons and patients who wish to use the technology.
CyberKnife is a robotic radiosurgical system from Accuray (Sunnyvale, California) designed to deliver high doses of targeted radiation to tumors almost anywhere in the body with sub-millimeter accuracy. It is especially effective at reaching and treating very small tumors and lesions. It has proven to be successful with lung cancer, prostate, intracranial, neck, liver, and pancreas.